Published in Indian J Anaesth on July 01, 2011
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71
Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol (2006) 2.16
Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J (2006) 1.81
Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med (2007) 1.67
Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med (2008) 1.58
Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol (2010) 1.49
Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart (2006) 1.40
Ischemia-modified albumin in acute stroke. Cerebrovasc Dis (2006) 1.17
Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem (2009) 1.07
Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem (2009) 1.06
Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. Acad Emerg Med (2009) 1.06
Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis (2006) 1.01
Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J (2010) 1.00
Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta (2007) 0.91
Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal (2008) 0.89
Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med (2010) 0.88
Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis (2007) 0.88
Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med (2010) 0.87
Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clin Chim Acta (2006) 0.86
Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study. Am J Emerg Med (2009) 0.86
Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod (2008) 0.86
Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels (2008) 0.85
Serum ischemia-modified albumin as a novel marker of ovarian torsion: an experimental study. Eur J Obstet Gynecol Reprod Biol (2010) 0.83
Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta (2009) 0.82
Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation (2009) 0.82
Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty? Biomarkers (2009) 0.81
Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy (2010) 0.81
Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Atherosclerosis (2008) 0.77
Ischemia-modified albumin levels in carbon monoxide poisoning. Am J Emerg Med (2010) 0.76
How pseudo is an inflammatory pseudotumor? Indian J Med Paediatr Oncol (2011) 0.75
We are what we breathe! Indian J Occup Environ Med (2011) 0.75
Revisiting endosulfan. J Family Med Prim Care (2012) 0.75
Endocrine disruptors: Ubiquitous, yet less known. Indian J Endocrinol Metab (2011) 0.75
Multiparity: A double-edged blessing of metabolic syndrome along with children. Indian J Endocrinol Metab (2012) 0.75
Finasteride and male fertility. J Hum Reprod Sci (2011) 0.75
Curcumin in neurology. J Neurosci Rural Pract (2012) 0.75
Management of pressure ulcers - What is new? J Midlife Health (2011) 0.75
Remembering what's new in Alzheimer's management. J Pharmacol Pharmacother (2011) 0.75
DRESSing up to phenytoin. Indian J Pharmacol (2011) 0.75